Assertio Holdings (ASRT) Enterprise Value (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Enterprise Value came in at -$71.6 million in Q1 2026, up 18.04% year-on-year from -$60.6 million in Q1 2025, and down 12.88% quarter-over-quarter from -$63.4 million in Q4 2025.
Assertio Holdings (ASRT) Enterprise Value (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Enterprise Value across 8 years of filings, most recently posting -$71.6 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$71.6 million, up 18.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$71.6 million (up 18.04% YoY), and the FY2025 annual result was -$63.4 million, up 36.63% from the prior year.
- Enterprise Value came in at -$71.6 million for Q1 2026 at Assertio Holdings, down from -$63.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$52.3 million in Q2 2022 to a low of -$100.1 million in Q4 2024.
- The 5-year median for Enterprise Value is -$73.4 million (2023), against an average of -$76.7 million.
- Across the five-year window, Enterprise Value slumped 76.42% in 2022 and soared 36.63% in 2025, its largest moves.
- Assertio Holdings' Enterprise Value stood at -$64.9 million in 2022, then decreased by 13.09% to -$73.4 million in 2023, then slumped by 36.24% to -$100.1 million in 2024, then jumped by 36.63% to -$63.4 million in 2025, then fell by 12.88% to -$71.6 million in 2026.
- The last three Enterprise Value figures came in at -$71.6 million (Q1 2026), -$63.4 million (Q4 2025), and -$93.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -71.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.57 Mn |
| Dec 31, 2025 | -63.41 Mn |
| Sep 30, 2025 | -93.43 Mn |
| Jun 30, 2025 | -98.18 Mn |
| Mar 31, 2025 | -87.33 Mn |
| Dec 31, 2024 | -100.05 Mn |
| Sep 30, 2024 | -88.58 Mn |
| Jun 30, 2024 | -88.38 Mn |
| Mar 31, 2024 | -80.74 Mn |
| Dec 31, 2023 | -73.44 Mn |
| Sep 30, 2023 | -76.89 Mn |
| Jun 30, 2023 | -70.18 Mn |
| Mar 31, 2023 | -68.60 Mn |
| Dec 31, 2022 | -64.94 Mn |
| Sep 30, 2022 | -64.83 Mn |
| Jun 30, 2022 | -52.26 Mn |
| Mar 31, 2022 | -61.39 Mn |
| Dec 31, 2021 | -36.81 Mn |
| Sep 30, 2021 | -58.73 Mn |
| Jun 30, 2021 | -54.43 Mn |